PLD plays an essential role in reducing ROS production and inhibiting the activation of NLRP3 inflammasome, thereby inhibiting pyroptosis and inflammatory damage in the HNEpCs of patients with CRS, as shown in Fig. 9. Here, NLRP3 is linked to congenital rubella syndrome.